Perspective Therapeutics (CATX) Net Income towards Common Stockholders (2010 - 2026)
Perspective Therapeutics recorded quarterly Net Income towards Common Stockholders of -$26.2 million in Q1 2026, down 5195.14% quarter-over-quarter from $514000.0 in Q2 2025.
Perspective Therapeutics' Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$26.2 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders changed N/A year-over-year to -$26.2 million; the TTM figure through Mar 2026 stood at -$25.7 million (down 5139.8% YoY), while the FY2025 annual figure was $514000.0, up 154.16% from the prior year.
- Net Income towards Common Stockholders came in at -$26.2 million for Q1 2026 at Perspective Therapeutics, down from $514000.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $514000.0 in Q2 2025 to a low of -$26.2 million in Q1 2026.
- A 5-year average of -$3.8 million and a median of -$1.5 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders tumbled 127.82% in 2023 and soared 204.9% in 2025, its largest moves.
- Perspective Therapeutics' Net Income towards Common Stockholders stood at -$2.3 million in 2022, then sank by 127.82% to -$5.2 million in 2023, then surged by 90.55% to -$490000.0 in 2024, then jumped by 204.9% to $514000.0 in 2025, then tumbled by 5195.14% to -$26.2 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$26.2 million, $514000.0, and -$490000.0 for Q1 2026, Q2 2025, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | -26.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.19 Mn |
| Jun 30, 2025 | 514,000.00 |
| Jun 30, 2024 | -490,000.00 |
| Mar 31, 2024 | -459,000.00 |
| Dec 31, 2023 | -5.18 Mn |
| Sep 30, 2023 | -784,000.00 |
| Jun 30, 2023 | -1.62 Mn |
| Mar 31, 2023 | -1.47 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | -4.07 Mn |
| Jun 30, 2022 | -2.08 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Dec 31, 2021 | -1.60 Mn |
| Sep 30, 2021 | -2.24 Mn |
| Jun 30, 2021 | -1.06 Mn |
| Mar 31, 2021 | -745,000.00 |
| Dec 31, 2020 | -868,000.00 |
| Sep 30, 2020 | -716,000.00 |
| Jun 30, 2020 | -1.19 Mn |
| Mar 31, 2020 | -548,000.00 |
| Dec 31, 2019 | -899,000.00 |
| Sep 30, 2019 | -819,000.00 |
| Jun 30, 2019 | -1.10 Mn |
| Mar 31, 2019 | -1.13 Mn |
| Dec 31, 2018 | -1.42 Mn |
| Sep 30, 2018 | -1.51 Mn |
| Jun 30, 2018 | -2.36 Mn |
| Mar 31, 2018 | -1.34 Mn |
| Dec 31, 2017 | -1.47 Mn |
| Sep 30, 2017 | -1.55 Mn |
| Jun 30, 2017 | -1.86 Mn |
| Mar 31, 2017 | -1.36 Mn |
| Dec 31, 2016 | -1.45 Mn |
| Sep 30, 2016 | -1.50 Mn |
| Jun 30, 2016 | -1.19 Mn |
| Mar 31, 2016 | -1.20 Mn |
| Dec 31, 2015 | -1.31 Mn |
| Sep 30, 2015 | -1.02 Mn |
| Jun 30, 2015 | -1.04 Mn |
| Mar 31, 2015 | -956,211.00 |
| Dec 31, 2014 | -909,612.00 |
| Sep 30, 2014 | -788,520.00 |
| Jun 30, 2014 | -1.68 Mn |
| Mar 31, 2014 | -2.09 Mn |
| Dec 31, 2013 | -929,630.00 |
| Sep 30, 2013 | -2.00 Mn |
| Jun 30, 2013 | -996,222.00 |
| Mar 31, 2013 | -717,695.00 |
| Dec 31, 2012 | -1.16 Mn |
| Sep 30, 2012 | -996,326.00 |
| Jun 30, 2012 | -1.21 Mn |
| Mar 31, 2012 | -555,544.00 |
| Dec 31, 2011 | -631,403.00 |
| Sep 30, 2011 | -1.10 Mn |
| Jun 30, 2011 | -714,655.00 |
| Mar 31, 2011 | -1.03 Mn |
| Dec 31, 2010 | -230,727.00 |
| Sep 30, 2010 | -874,540.00 |